Physician profile
Lindsey Minshew
NPI 1700143468
$621.32
in general payments reported to CMS, 2019-2025
15 companies · $23.14 in 2025
The $23.14 reported for 2025 was less than what a typical Diagnostic Radiology provider received nationally (typical 2025 total: $112).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $101 · 2024: $498 · 2025: $23.14.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $621.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $621.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $82.26 | 2024 | Verzenio, Jaypirca, Retevmo |
| Janssen Biotech, INC. | $76.84 | 2024 | Rybrevant, Carvykti |
| Merck Sharp & Dohme LLC | $62.08 | 2024 | Keytruda, Welireg |
| Organon LLC | $60.81 | 2023-2024 | Ontruzant |
| Pharmaessentia USA Corporation | $52.31 | 2024 | Besremi |
| Boehringer Ingelheim Pharmaceuticals, INC. | $43.44 | 2024-2025 | Jardiance |
| Karyopharm Therapeutics INC. | $34.82 | 2024 | Xpovio |
| Astrazeneca Pharmaceuticals LP | $33.54 | 2024 | Tagrisso |
| Ipsen Biopharmaceuticals, INC | $29.88 | 2024 | Onivyde |
| Blue Earth Diagnostics | $29.07 | 2024 | |
| Incyte Corporation | $26.41 | 2024 | Jakafi |
| Puma Biotechnology, INC. | $26.08 | 2023 | |
| Foundation Medicine, INC. | $22.39 | 2023 | |
| Sobi, INC | $22.35 | 2024 | |
| Bayer Healthcare Pharmaceuticals INC. | $19.04 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Minshew listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.